Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | ||||
| Anaphylactic shock | Anaphylactic shock | x | x | ||||
| Hypersensitivity | Hypersensitivity | x | x | ||||
| Hypertension | Hypertension | x | x | x | |||
| Hypoglycaemic coma | Hypoglycaemic coma | x | x | ||||
| Hypotension | Hypotension | x | x | x | |||
| Nausea | Nausea | x | x | x | x | ||
| Tachycardia | Tachycardia | x | x | x | |||
| Vomiting | Vomiting | x | x | x | x | ||
| Blood pressure increased | Blood pressure increased | x | x | x | |||
| Drug interaction | Drug interaction | x | x | ||||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |